期刊
DIABETES
卷 58, 期 10, 页码 2344-2354出版社
AMER DIABETES ASSOC
DOI: 10.2337/db09-0167
关键词
-
资金
- National Institutes of Health [P01-HL-87123, P30-DK-63608]
- Columbia Diabetes & Endocrinology Research Center
OBJECTIVE-Atherosclerotic cardiovascular disease is the leading cause of death among people with diabetes. Generation of oxidized LDLs and reduced nitric oxide (NO) availability because of endothelial NO synthase (eNOS) dysfunction are critical events in atherosclerotic plaque formation. Biochemical mechanism leading from hyperglycemia to oxLDL formation and eNOS dysfunction is unknown. RESEARCH DESIGN AND METHODS-We show that glucose, acting through oxidative stress, activates the transcription factor Foxol in vascular endothelial cells. RESULTS-Foxol promotes inducible NOS (iNOS)-dependent NO-peroxynitrite generation, which leads in turn to LDL oxidation and eNOS dysfunction. We demonstrate that Foxol gain-of-function mimics the effects of hyperglycemia on this process, whereas conditional Foxol knockout in vascular endothelial cells prevents it. CONCLUSIONS-The findings reveal a hitherto unsuspected role of the endothelial iNOS-NO-peroxynitrite pathway in lipid peroxidation and eNOS dysfunction and suggest that Foxol activation in response to hyperglycemia brings about proatherogenic changes in vascular endothelial cell function. Diabetes 58: 2344-2354, 2009
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据